Smartphone-based Measurements of Deformational Plagiocephaly and Brachycephaly: A Prospective Study
Sunday, April 24, 2022
1:00 PM – 1:15 PM US MT
Location: Convention Center: 603
CE: Enduring CME: 0.25
Publication Number: 2565.1
Can Kocabalkanli, PediaMetrix, Rockville, MD, United States; Regina Fenton, UPMC Childrens Hospital of Pittsburgh, Carnegie, PA, United States; Susan A. Gaetani, UPMC Childrens Hospital of Pittsburgh, Franklin, MA, United States; Fereshteh Aalamifar, PediaMetrix, North Potomac, MD, United States; Marius George Linguraru, Pediametrix Inc., Washington, DC, United States; Reza Seifabadi, PediaMetrix, Rockville, MD, United States
Presenting Author(s)
Can Kocabalkanli, MSc
Computer Vision Research Engineer PediaMetrix Rockville, Maryland, United States
Participants should be aware of the following financial/non-financial relationships:
Can Kocabalkanli, MSc: ● PediaMetrix Inc. (Currently Ongoing) (Products/Services: Employment with an ineligible company, Ownership Interest including individual stocks, stock options, excluding diversified mutual funds).
Regina Fenton, RN, MSN, CRNP: ● PediaMetrix (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator).
Susan A. Gaetani, DPT: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Fereshteh Aalamifar, Aalamifar, PhD: ● PediaMetrix (Currently Ongoing) (Products/Services: Employment with an ineligible company, Intellectual Property including patent beneficiary and royalties, Board Member or Executive Role, Ownership Interest including individual stocks, stock options, excluding diversified mutual funds).
Marius George Linguraru, DPhil, MA, MSc: ● PediaMetrix Inc (Currently Ongoing) (Products/Services: Employment with an ineligible company, Research Support including clinical trials & the principal or named investigator, Board Member or Executive Role, Ownership Interest including individual stocks, stock options, excluding diversified mutual funds).
Reza Seifabadi, PhD: ● PediaMetrix (Currently Ongoing) (Products/Services: Employment with an ineligible company, Ownership Interest including individual stocks, stock options, excluding diversified mutual funds).
